Thank you for joining us in May 2025, in Seattle, Washington for a two-and-a-half day program that brought together leaders and trainees in research and clinical care of infectious diseases in the ...

Live-attenuated viral vaccines (LAV) have been used safely for several decades in healthy individuals to protect against diseases with great success. In immunocompromised hosts their use is usually ...

A target trial emulation was conducted to assess the effectiveness of recombinant zoster vaccine (RZV) accounting for prior receipt of live zoster vaccine (ZVL) and immunocompetence.

Human cytomegalovirus (HCMV) is a ubiquitous member of the Betaherpesvirinae that infects the majority of the human population. Although primary infection is often asymptomatic in immunocompetent ...